World Hepatitis Alliance

09/09/2026

The World Hepatitis Alliance has been nominated for the following Memcom excellence awards:
• For its work on the Community Impact Programme, the Best Educational Initiative award
• For its work with hepatitis and liver cancer interest organisations, the Best Collaborative Partnership and
• For its work with the World Hepatitis Alliance members, the Best Membership Support

As communicated by Memcom, this year’s shortlist reflects the outstanding innovation, creativity and impact happening across the membership, association, charity and NFP sectors.

We’re pleased to be nominated amongst this cohort for our work driving awareness of hepatitis, the importance of its elimination, and what it will take to get there by 2030.

Learn more about WHA's mission here: https://www.worldhepatitisalliance.org/about/

08/09/2026

World Hepatitis Alliance partner, The European Association for the Study of the Liver (EASL) has launched a new course titled Preventive Hepatology.

Based on the latest findings of the EASL Lancet Commission 2.0, this course seeks to empower healthcare professionals to prevent liver disease through policy, advocacy and the latest research.

Interested in developing these skills? Enrol here:

Policy, Public Health & Advocacy Liver disease is one of Europe’s most serious yet least visible health threats — and […]

07/09/2026

We recently facilitated a SAFEStart+ Country Community Advisory Board (C-CAB) presentation & community dialogue in Asunción, Paraguay.

The objective of the meeting was to launch the call for the C-CAB, present the project to community organisations, and invite them to apply. A community dialogue was also held to hear about barriers to testing, linkage to care, and elimination of vertical transmission.

Curious as to what a C-CAB is? Find out more here:

Discover how SAFEStart+ Community Advisory Boards ensure local voices shape programmes, strengthen partnerships and improve health outcomes.

04/09/2026

The World Hepatitis Alliance will be at the 2026 International HBV Meeting in Singapore!

Join us on Sunday 6 September 2026 at 1pm for a panel discussion on the lived experience of hepatitis B and D in Asia.

The conference will an opportunity to engage in a focused exchange on the latest unpublished research and emerging data. To learn more about hepatitis B and D, have a look at our resources: https://www.worldhepatitisalliance.org/what-is-viral-hepatitis/

03/09/2026

"Before CIP, my case for the hepatitis B birth dose was built almost entirely on health grounds. The programme taught me to frame the ask differently, tying it to cost savings and health system efficiency, which is the language policymakers actually respond to." - Duke Sangara, Public Health Expert, Kenya

We're proud to present to you a second case study from the fourth cohort of participants in the World Hepatitis Alliance Community Impact Programme.

Through this accelerator programme, the WHA equips participants with the diverse skills and practical knowledge necessary to strengthening their advocacy efforts in the fight against viral hepatitis.

Read about Duke's experience, and how he has used the learning of the programme since it ended, here: https://www.worldhepatitisalliance.org/community-impact-programme-group-4/

02/09/2026

Liver cancer is the third most common cause of cancer deaths worldwide, with many of these cases preventable through hepatitis testing, treatment and vaccination.
This Global Week for Action on NCDs, learn more about the World Hepatitis Alliance's work on liver cancer prevention through hepatitis elimination: https://www.worldhepatitisalliance.org/liver-cancer-and-ncds/

28/08/2026

The World Hepatitis Alliance will be at the 9th Conference on Liver Disease in Africa (COLDA)!

Join us on Thursday 17 September 2026 for a discussion on the importance of dialogue between communities, implementers and policymakers, in the elimination of hepatitis.

This is an opportunity to engage with leading experts, and contribute to discussions shaping the future of liver disease prevention, diagnosis, and care across the African continent.

Hybrid event focusing on Viral Hepatitis and Liver Disease, Viral Hepatitis and Liver Disease. 2026-09-17 to 2026-09-19 in Addis Ababa

27/08/2026

"Public health challenges like hepatitis need innovative ideas, and learning with the rest of the world will open those doors." - Dr Shailesh Wagle, United Way Mumbai

In the first case study from the fourth cohort of participants in the WHA Community Impact Programme, Shailesh speaks about how the programme equipped him with advocacy tools necessary for the fight against viral hepatitis.

Read about Shailesh's experience, and find out more about the programme here: https://www.worldhepatitisalliance.org/community-impact-programme-group-4/

26/08/2026

This Wednesday, we’re shining a light on World Hepatitis Alliance member, the Patient and Community Welfare Foundation of Malawi (PAWEM).

On 28 July, PAWEM led a Hepatitis B Awareness Walk in Chikwawa district, Malawi, as part of the STOP-HBV project, and in commemoration of World Hepatitis Day.

The walk sought to raise community awareness of Hepatitis B, and promote testing, vaccination, treatment and prevention of mother-to-child transmission.

Let’s break down the barriers holding us back from a hepatitis-free world. Watch this video to get the facts: https://www.youtube.com/watch?v=dbKXz-3HCrU

25/08/2026

The World Hepatitis Alliance is pleased to have co-authored a comparative analysis of liver cancer, and lung cancer with partner, the Center for Disease Analysis Foundation.

The findings show that there is a greater chance of a viral hepatitis infection leading to liver cancer than there is of current smoking leading to lung cancer.

For information on how we beat cancer through hepatitis elimination, read this WHA authored white paper: https://www.worldhepatitisalliance.org/resource-downloads/

https://onlinelibrary.wiley.com/doi/10.1111/jvh.70222